Fragment-based drug discovery: Less is more

被引：0
|
作者：
Heightman, Tom D. [1 ]
机构：
[1] Astex Pharmaceut Inc, Cambridge, England
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
PROTEINS; IAP;
D O I：
10.1158/1538-7445.AM2014-SY05-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY05-01
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Advances in fragment-based drug discovery platforms
    Orita, Masaya
    Warizaya, Masaichi
    Amano, Yasushi
    Ohno, Kazuki
    Niimi, Tatsuya
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (11) : 1125 - 1144
  • [22] NMR Screening in the Fragment-based Drug Discovery
    Hanzawa, Hiroyuki
    Takizawa, Takeshi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (03): : 325 - 333
  • [23] What makes a good fragment in fragment-based drug discovery?
    Konteatis, Zenon
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (07) : 723 - 726
  • [24] Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
    Konaklieva, Monika I.
    Plotkin, Balbina J.
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [25] Fragment-Based Drug Discovery and Molecular Docking in Drug Design
    Wang, Tao
    Wu, Mian-Bin
    Chen, Zheng-Jie
    Chen, Hua
    Lin, Jian-Ping
    Yang, Li-Rong
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2015, 16 (01) : 11 - 25
  • [26] Fragment-based drug discovery using rational design
    Jhoti, H.
    SPARKING SIGNALS: KINASES AS MOLECULAR SIGNAL TRANSDUCERS AND PHARMACOLOGICAL DRUG TARGETS IN INFLAMMATION, 2008, 3 : 169 - 185
  • [27] Fragment-based drug discovery takes a virtual turn
    Maurizio Pellecchia
    Nature Chemical Biology, 2009, 5 : 274 - 275
  • [28] Application of Fragment-Based Drug Discovery to Versatile Targets
    Li, Qingxin
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [29] Fragment-based drug discovery using the SHAPES method
    Lepre, Christopher
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (12) : 1555 - 1566
  • [30] Fragment-based drug discovery: opportunities for organic synthesis
    St Denis, Jeffrey D.
    Hall, Richard J.
    Murray, Christopher W.
    Heightman, Tom D.
    Rees, David C.
    RSC MEDICINAL CHEMISTRY, 2021, 12 (03): : 321 - 329
12345